Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page
- CheckyesterdayChange DetectedA sitewide banner announces updates to NIH websites and describes the transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 Forbidden error, while its footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record page now displays a 403 Forbidden error page, replacing the study details with a standard error screen and site footer.SummaryDifference18%

- Check56 days agoChange DetectedThe revision label changed from v3.6.5 to v3.6.6, indicating a small backend or UI update to the page; no study text or results are affected.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.6.5 added. The change represents an update to the page's revision metadata rather than substantive study information.SummaryDifference16%

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.